Innate Pharma S.A. (FR:IPH) has released an update.
Innate Pharma S.A., a clinical-stage biotechnology company, has announced its Annual General Meeting (AGM) scheduled for May 23, 2024, at its Marseille headquarters. Shareholders are invited to participate in the AGM and a guided tour of the company’s laboratories, with preparatory documents available on Innate’s website. The company highlights its focus on developing immunotherapies for cancer and partnerships with industry leaders to enhance patient care.
For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.
